Deterioration of gas exchange in patients with severe thrombotic thrombocytopenic purpura with respiratory failure during therapeutic plasma exchange

Therapeutic plasma exchange (TPE) is a procedure performed on patients suffering from various disorders, including thrombotic thrombocytopenic purpura (TTP). As we noted a frequent transient deterioration in respiratory function when the procedure was performed on intensive care unit (ICU) patients, we studied retrospectively the incidence of respiratory deterioration during and shortly after TPE and looked for a probable correlation with a change in the white blood cell (WBC) counts. Over a period of 10 months six patients with TTP, five of whom had parenchymal lung disease due to different medical reasons, underwent TPE. The oxygen saturation was measured continuously before, during, and after TPE; additionally, the WBC and differential counts were measured pre‐ and post‐TPE. The ratio of the oxygen saturation by pulse oxymetry (SpO2) to the fraction of inspired oxygen (FiO2) was calculated before, during and after TPE. In these five patients with lung disorders, there was a consistent trend of a decreasing SpO2/FiO2 quotient during and within 2 h post TPE compared to the pre‐TPE value. The decrease in SpO2/FiO2 range was 0.20–0.89 with an average of 0.56. In the same 5 patients there was an increase in the WBC count in the range of 2.3–19.7 × 109/L with an average increase of 9.3 × 109/L. The percent neutrophils of the total WBC counts also increased following most of the sessions, this increase was in the range of 1–15 % with an average of 7%. The effect of TPE on the SpO2/FiO2 ratio and the correlation to the WBC count and to a possible neutrophil activation has not been previously reported. We postulate that TPE can accentuate respiratory deterioration in patients with TTP who already have acute lung injury. This may be due to the priming and activation of the leukocytes that could lead to the release of cytokines and inflammatory mediators during the procedure. Thus, it is important to be aware of the possible deterioration in respiratory function and gas exchange while administering TPE to patients with pre‐existing parenchymal lung injury. J. Clin. Apheresis. 16:143‐147, 2000. © 2001 Wiley‐Liss, Inc.

[1]  Dutcher Transfusion Therapy: Clinical Principles and Practice. , 2000, Annals of internal medicine.

[2]  J. Christman,et al.  Nuclear factor k B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy , 1998, Intensive Care Medicine.

[3]  J. Moake,et al.  Thrombotic thrombocytopenic purpura: understanding a disease no longer rare. , 1998, The American journal of the medical sciences.

[4]  E. Faist,et al.  SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS), MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS), MULTIPLE ORGAN FAILURE (MOF): ARE WE WINNING THE BATTLE? , 1998, Shock.

[5]  R. Strieter,et al.  Acute lung injury: the role of cytokines in the elicitation of neutrophils. , 1994, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[6]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[7]  C. Nathan,et al.  Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins , 1989, The Journal of cell biology.

[8]  C. Nathan Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. , 1987, The Journal of clinical investigation.

[9]  P. Henson,et al.  Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. , 1987, The Journal of clinical investigation.

[10]  R. T. Carroll MANAGEMENT OF TRANSFUSION REACTIONS. , 1963, The American journal of cardiology.

[11]  B. Smith,et al.  Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass. , 1994, The Journal of thoracic and cardiovascular surgery.

[12]  C. Nathan Coordinate Actions of Growth Factors in Monocytes/Macrophages , 1990 .